{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:49:52Z","timestamp":1791924592431,"version":"4.3.4"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:p>\n            Primary aldosteronism affects \u22485% to 10% of hypertensive patients and has unilateral and bilateral forms. Most unilateral primary aldosteronism is caused by computed tomography-detectable aldosterone-producing adenomas, which express CYP11B2 (aldosterone synthase) and frequently harbor somatic mutations in aldosterone-regulating genes. The cause of the most common bilateral form of primary aldosteronism, idiopathic hyperaldosteronism (IHA), is believed to be diffuse hyperplasia of aldosterone-producing cells within the adrenal cortex. Herein, a multi-institution cohort of 15 IHA adrenals was examined with CYP11B2 immunohistochemistry and next-generation sequencing. CYP11B2 immunoreactivity in adrenal glomerulosa harboring non-nodular hyperplasia was only observed in 4\/15 IHA adrenals suggesting that hyperplasia of CYP11B2-expressing cells may not be the major cause of IHA. However, the adrenal cortex of all IHA adrenals harbored at least 1 CYP11B2-positive aldosterone-producing cell cluster (APCC) or micro-aldosterone-producing adenomas. The number of APCCs per case (and individual APCC area) in IHA adrenals was significantly larger than in normotensive controls. Next-generation sequencing of DNA from 99 IHA APCCs demonstrated somatic mutations in genes encoding the L-type calcium voltage-gated channel subunit \u03b1 1-D (\n            <jats:italic>CACNA1D<\/jats:italic>\n            , n=57; 58%) and potassium voltage-gated channel subfamily J-5 (\n            <jats:italic>KCNJ5<\/jats:italic>\n            , n=1; 1%). These data suggest that IHA may result from not only hyperplasia but also the accumulation or enlargement of computed tomography-undetectable APCC harboring somatic aldosterone-driver gene mutations. The high prevalence of mutations in the\n            <jats:italic>CACNA1D<\/jats:italic>\n            L-type calcium channel provides a potential actionable therapeutic target that could complement mineralocorticoid blockade and inhibit aldosterone overproduction in some IHA patients.\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.118.11086","type":"journal-article","created":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T08:41:31Z","timestamp":1537087291000},"page":"874-880","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":198,"title":["Cellular and Genetic Causes of Idiopathic Hyperaldosteronism"],"prefix":"10.1161","volume":"72","author":[{"given":"Kei","family":"Omata","sequence":"first","affiliation":[{"name":"From the Department of Pathology (K.O., S.K.A., S.A.T.), University of Michigan, Ann Arbor"},{"name":"Division of Nephrology, Endocrinology and Vascular Medicine (K.O., F.S., R.M., S.I.), Tohoku University, Miyagi, Japan"},{"name":"Division of Clinical Hypertension, Endocrinology and Metabolism (K.O., F.S.), Tohoku University, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitoshi","family":"Satoh","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology and Vascular Medicine (K.O., F.S., R.M., S.I.), Tohoku University, Miyagi, Japan"},{"name":"Division of Clinical Hypertension, Endocrinology and Metabolism (K.O., F.S.), Tohoku University, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology and Vascular Medicine (K.O., F.S., R.M., S.I.), Tohoku University, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadayoshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology and Vascular Medicine (K.O., F.S., R.M., S.I.), Tohoku University, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Pathology (Y.Y., Y.N., H.S.), Tohoku University, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pathology (Y.Y., Y.N., H.S.), Tohoku University, Miyagi, Japan"},{"name":"Division of Pathology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Miyagi, Japan (Y.N.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharath K.","family":"Anand","sequence":"additional","affiliation":[{"name":"From the Department of Pathology (K.O., S.K.A., S.A.T.), University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng","family":"Guo","sequence":"additional","affiliation":[{"name":"Endocrine Hypertension Research Centre, University of Queensland Diamantina Institute, Greenslopes and Princess Alexandra Hospitals, Brisbane, Australia (Z.G., M.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stowasser","sequence":"additional","affiliation":[{"name":"Endocrine Hypertension Research Centre, University of Queensland Diamantina Institute, Greenslopes and Princess Alexandra Hospitals, Brisbane, Australia (Z.G., M.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[{"name":"Department of Pathology (Y.Y., Y.N., H.S.), Tohoku University, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Tomlins","sequence":"additional","affiliation":[{"name":"From the Department of Pathology (K.O., S.K.A., S.A.T.), University of Michigan, Ann Arbor"},{"name":"Michigan Center for Translational Pathology (S.A.T.), Department of Urology (S.A.T.), Comprehensive Cancer Center (S.A.T.), University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Rainey","sequence":"additional","affiliation":[{"name":"Department of Molecular and Integrative Physiology (W.E.R.), and Department of Medicine (W.E.R.), University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6545a3"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000152"},{"key":"e_1_3_4_4_2","first-page":"1","article-title":"Deaths: final data for 2009.","volume":"60","author":"Kochanek KD","year":"2011","unstructured":"Kochanek KD, Xu J, Murphy SL, Mini\u00f1o AM, Kung HC. Deaths: final data for 2009. Natl Vital Stat Rep. 2011;60:1\u2013116.","journal-title":"Natl Vital Stat Rep"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.07.059"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031337"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30319-4"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3726"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1053\/meta.2002.30498"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2986"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1198785"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2716"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2550"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2695"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03419"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03346"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep11396"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.5551\/jat.24455"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep19546"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147590"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12873"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.57.4.5"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2013.11.022"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2010"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2014.05.002"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1505529112"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.028201"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/js.2017-00134"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-1161"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcm101"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4061"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.02097"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4471-1317-1_15"},{"key":"e_1_3_4_34_2","first-page":"596","volume-title":"Functional Endocrine Pathology","author":"Lack EE","year":"1998","unstructured":"Lack EE. Functional Endocrine Pathology. Malden, MA: Blackwell Science; 1998:596\u2013636."},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000255"},{"key":"e_1_3_4_36_2","first-page":"168","article-title":"Secondary aldosteronism and reduced plasma renin in hypertensive disease.","volume":"80","author":"Ledingham JG","year":"1967","unstructured":"Ledingham JG, Laragh JH, Sommers SC. Secondary aldosteronism and reduced plasma renin in hypertensive disease. Trans Assoc Am Physicians. 1967;80:168\u2013182.","journal-title":"Trans Assoc Am Physicians"},{"key":"e_1_3_4_37_2","first-page":"195","article-title":"The intercurrent hypertension of primary aldosteronism.","volume":"27","author":"Biglieri EG","year":"1970","unstructured":"Biglieri EG, Schambelan M, Slaton PE, Stockigt JR. The intercurrent hypertension of primary aldosteronism. Circ Res. 1970;27(1 suppl 1):195\u2013202.","journal-title":"Circ Res"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(65)90122-1"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/pin.12200"},{"key":"e_1_3_4_40_2","first-page":"203","article-title":"Pseudo-primary aldosteronism. An entity distinct from true primary aldosteronism.","volume":"27","author":"Baer L","year":"1970","unstructured":"Baer L, Sommers SC, Krakoff LR, Newton MA, Laragh JH. Pseudo-primary aldosteronism. An entity distinct from true primary aldosteronism. Circ Res. 1970;27(1 suppl 1):203\u2013220.","journal-title":"Circ Res"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1510073"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(67)90065-4"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-67-5-1035"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199812173392507"},{"key":"e_1_3_4_45_2","first-page":"335","article-title":"Primary aldosteronism due to adrenocortical hyperplasia.","volume":"271","author":"Doorenbos H","year":"1956","unstructured":"Doorenbos H, Elings HS, van Buchem FS. Primary aldosteronism due to adrenocortical hyperplasia. Lancet. 1956;271:335\u2013337.","journal-title":"Lancet"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-90-3-386"},{"key":"e_1_3_4_47_2","first-page":"389","article-title":"Primary aldosteronism versus hypertensive disease with secondary aldosteronism.","volume":"17","author":"Conn JW","year":"1961","unstructured":"Conn JW, Conn ES. Primary aldosteronism versus hypertensive disease with secondary aldosteronism. Recent Prog Horm Res. 1961;17:389\u2013414.","journal-title":"Recent Prog Horm Res"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.02775.x"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.76.6.973"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040135"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60834-X"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2010.05352.x"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2149"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep24697"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.118.11086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T08:10:24Z","timestamp":1738829424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.118.11086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.118.11086"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.118.11086","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"2018-02-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}